RCAN1 and Alzheimer disease: Therefore, our data indicate that chronic overexpression of DSCR1 is detrimental to Aβ42-induced neurotoxicity, and that increased expression of DSCR1 in the brain of individuals with DS or AD might exacerbate AD pathogenesis.